Eisai Co., Ltd. (ESAIY)
OTCMKTS
· Delayed Price · Currency is USD
7.09
+0.02 (0.28%)
Jul 3, 2025, 12:59 PM EDT
Eisai Employees
Eisai had 10,917 employees as of March 31, 2025. The number of employees decreased by 150 or -1.36% compared to the previous year.
Employees
10,917
Change (1Y)
-150
Growth (1Y)
-1.36%
Revenue / Employee
$482,873
Profits / Employee
$28,402
Market Cap
8.06B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Endo, Inc. | 3,116 |
| Elite Pharmaceuticals | 64 |
| Tian'an Technology Group | 8 |
| Glass House Brands | 374 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 9 |
| Silence Therapeutics | 116 |
Eisai News
- 26 days ago - Eisai: Leqembi Approved In EU (Rating Downgrade) - Seeking Alpha
- 7 weeks ago - Eisai Co., Ltd. (ESALF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - EU authorizes Eisai-Biogen's drug for treatment of early Alzheimer's disease - Reuters
- 4 months ago - EU regulator not updating opinion on Eisai-Biogen's Alzheimer's drug - Reuters
- 4 months ago - Eisai: Will Have No Problem Hitting Leqembi Forecasts - Seeking Alpha
- 5 months ago - Eisai Co., Ltd. (ESALF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Europe to review safety data for Eisai-Biogen Alzheimer's drug - Reuters
- 5 months ago - US FDA OKs monthly maintenance dosing for Eisai/Biogen's Alzheimer's drug - Reuters